Regado Biosciences,Inc. Completes $40 Million Series D Financing (PR Newswire)
17.12.2009 - 18:32
Regado Biosciences,Inc.,a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents,today announced the completion of a $40 million Series D financing.